| Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer (NCT02562118) | National University Hospital, Singapore | 2015-10-02 |
| A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C (NCT02564497) | Bristol-Myers Squibb | 2015-10-02 |
| Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy (NCT02460094) | Biogen | 2015-10-02 |
| A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF) (NCT02407353) | Pfizer | 2015-10-01 |
| Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. (NCT02623868) | Chong Kun Dang Pharmaceutical | 2015-10-01 |
| Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma (NCT02592395) | The University of Texas Health Science Center, Houston | 2015-10-01 |
| Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain (NCT02372175) | U.S. Army Medical Research and Development Command | 2015-10-01 |
| Brava and Fat Transfer for Breast Reconstruction (NCT02583607) | Shaare Zedek Medical Center | 2015-10-01 |
| Comparison Between Stair Climbing and One Mile Walking in Relation to Cardiorespiratory Fitness (NCT02645292) | Universiti Tunku Abdul Rahman | 2015-10-01 |
| DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria (NCT02450578) | Medicines for Malaria Venture | 2015-10-01 |
| A Pharmacokinetics Study of AF-130 in Healthy Subjects (NCT02652936) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-10-01 |
| Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors (NCT02604784) | Fondazione del Piemonte per l'Oncologia | 2015-10-01 |
| Single Ascending Oral Dose Study of F901318 (NCT02394483) | F2G Ltd | 2015-10-01 |
| A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 (NCT02581072) | Novan, Inc. | 2015-10-01 |
| A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax (NCT02572635) | ImmunoBiology Limited | 2015-10-01 |
| An Innovative Treatment for Fistula-in-ano in Crohn Disease : Local Micro Reinjection of Autologous Fat and SVF (NCT02520843) | Assistance Publique Hopitaux De Marseille | 2015-10-01 |
| The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM (NCT02582840) | AstraZeneca | 2015-10-01 |
| Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss (NCT02616172) | James Baumgartner, MD | 2015-10-01 |
| Methylprednisolone Combined Electric-acupuncture on Cognitive Function (NCT02535039) | Shengjing Hospital | 2015-10-01 |
| Allogeneic CART-33 for Relapsed/Refractory CD33+ AML (NCT02799680) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2015-10-01 |
| ANF-Rho in the Treatment of Chronic Neutropenia (NCT02533362) | Prolong Pharmaceuticals | 2015-10-01 |
| A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma (NCT02594384) | OrphAI Therapeutics | 2015-10-01 |
| Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects (NCT02568098) | University of Oxford | 2015-10-01 |
| PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers (NCT02715401) | Hanmi Pharmaceutical Company Limited | 2015-10-01 |
| Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02606123) | ESSA Pharmaceuticals | 2015-10-01 |
| Phase I Pharmacokinetic Study of RX0041-2 (NCT02667106) | Pharmaceutical Project Solutions, Inc. | 2015-10-01 |
| Probiotic Supplementation in Breastfed Newborn Infants (NCT02286999) | Emanual Maverakis, MD | 2015-10-01 |
| Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms (NCT02569697) | CONRAD | 2015-10-01 |
| PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma (NCT02557321) | Provectus Biopharmaceuticals, Inc. | 2015-10-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers (NCT02587442) | Original BioMedicals Co. Ltd. | 2015-10-01 |
| Study of Metatinib Tromethamine Tablet (NCT02650375) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2015-10-01 |
| A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours (NCT02521844) | EDDC (Experimental Drug Development Centre), A*STAR Research Entities | 2015-10-01 |
| A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients (NCT02727309) | Peking University Cancer Hospital & Institute | 2015-10-01 |
| A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer (NCT02432612) | GW Pharmaceuticals Ltd | 2015-10-01 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Rivipansel With rHuPH20 in Healthy Subjects (NCT02217917) | GlycoMimetics Incorporated | 2015-10-01 |
| Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China (NCT03019991) | Ascletis Pharmaceuticals Co., Ltd. | 2015-10-01 |
| Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability (NCT02581553) | Ardea Biosciences, Inc. | 2015-10-01 |
| Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT02403193) | Palobiofarma SL | 2015-10-01 |
| Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer (NCT02582801) | Jiang Wu | 2015-10-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso (NCT02580747) | Chinese PLA General Hospital | 2015-10-01 |
| A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects (NCT02654626) | KBP Biosciences | 2015-10-01 |
| Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer (NCT02353819) | University of Texas Southwestern Medical Center | 2015-10-01 |
| Relative Bioavailability of Three Oral Formulations Candidates of Rilpivirine for Potential Pediatric Use Compared to Oral Tablet (NCT02561936) | Janssen Sciences Ireland UC | 2015-10-01 |
| Serine Supplementation for Obese Subjects With Fatty Liver Disease (NCT02599038) | Hanns-Ulrich Marschall | 2015-10-01 |
| Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet (NCT02589457) | Chong Kun Dang Pharmaceutical | 2015-10-01 |
| A Study of [¹⁴C]-LY3023414 in Healthy Participants (NCT02575703) | Eli Lilly and Company | 2015-10-01 |
| A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL (NCT02518113) | Eli Lilly and Company | 2015-10-01 |
| Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects (NCT02573155) | AstraZeneca | 2015-10-01 |
| Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor (NCT02587689) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2015-10-01 |
| A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients (NCT02619058) | Peking University Cancer Hospital & Institute | 2015-10-01 |
| Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome (NCT02544659) | Peking Union Medical College Hospital | 2015-10-01 |
| Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants (NCT02568176) | Janssen Research & Development, LLC | 2015-10-01 |
| A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects (NCT02623296) | Lakefront Biotherapeutics NV | 2015-10-01 |
| Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers (NCT02612506) | Shanghai HEP Pharmaceutical Co., Ltd. | 2015-10-01 |
| Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers (NCT02648854) | Chong Kun Dang Pharmaceutical | 2015-10-01 |
| A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients (NCT02473731) | Celldex Therapeutics | 2015-10-01 |
| Traumatic Brain Injury and Yoga (NCT03008434) | Colorado State University | 2015-10-01 |
| A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma (NCT03071042) | Sir Run Run Shaw Hospital | 2015-10-01 |
| PCO-02 - Safety and Pharmacokinetics Trial (NCT02637284) | PharmaCotherapia d.o.o. | 2015-10-01 |
| Topical Irrigation Therapy for CRS (NCT02630472) | University of Pennsylvania | 2015-10-01 |
| Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients (NCT02511184) | Pfizer | 2015-10-01 |
| Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis (NCT02534636) | Bristol-Myers Squibb | 2015-10-01 |
| Intranasal Oxytocin and Enhancement of Team Cohesion (NCT02302430) | University of California, San Francisco | 2015-10-01 |
| The Effect of Mobilization With Movement on Pain and Function Among Patients With Knee Osteoarthritis (NCT02865252) | Imam Abdulrahman Bin Faisal University | 2015-10-01 |
| Gabapentin as Adjunctive Treatment for Postoperative Pain Control (NCT02490345) | Indiana University | 2015-10-01 |
| Selinexor and Backbone Treatments of Multiple Myeloma Patients (NCT02343042) | Karyopharm Therapeutics Inc | 2015-10-01 |
| MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma (NCT02514824) | Dana-Farber Cancer Institute | 2015-10-01 |
| Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma (NCT02542657) | Joseph Tuscano | 2015-10-01 |
| A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects (NCT02590289) | Fresh Tracks Therapeutics, Inc. | 2015-10-01 |
| A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (NCT02573857) | Medicines for Malaria Venture | 2015-10-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects (NCT02571855) | Idorsia Pharmaceuticals Ltd. | 2015-10-01 |
| Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction (NCT02584686) | Cairo University | 2015-10-01 |
| [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis (NCT02606630) | AbbVie | 2015-10-01 |
| Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers (NCT02572349) | Cyclerion Therapeutics | 2015-10-01 |
| Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia (NCT02588456) | University of Pennsylvania | 2015-10-01 |
| Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL (NCT02799550) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2015-10-01 |
| Safety and Tolerability of TG1050: A Dose-finding Study (NCT02428400) | Transgene | 2015-10-01 |
| Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease (NCT02581124) | Akros Pharma Inc. | 2015-10-01 |
| Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) (NCT02593045) | Innate Pharma | 2015-10-01 |
| Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects (NCT02536391) | Genentech, Inc. | 2015-10-01 |
| Intraoperative Imaging of Pituitary Adenomas by OTL (NCT02629549) | University of Pennsylvania | 2015-10-01 |
| Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) (NCT02445963) | U.S. Army Medical Research and Development Command | 2015-10-01 |
| Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects (NCT02539576) | ViiV Healthcare | 2015-10-01 |
| Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer (NCT02592213) | Odense University Hospital | 2015-10-01 |
| Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (NCT02512302) | Sunovion Respiratory Development Inc. | 2015-10-01 |
| A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers (NCT02561884) | Daewoong Pharmaceutical Co. LTD. | 2015-10-01 |
| URMC Related Haplo-identical Donor BMT (NCT02660281) | University of Rochester | 2015-10-01 |
| Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone (NCT02380313) | GlaxoSmithKline | 2015-10-01 |
| Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM (NCT02597400) | Hua Medicine Limited | 2015-10-01 |
| Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers (NCT02501109) | CMG Pharmaceutical Co. Ltd | 2015-10-01 |
| Specificity of Dyspnoea Relief With Inhaled Furosemide (NCT02881866) | Oxford Brookes University | 2015-10-01 |
| A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients (NCT02608437) | Italian Network for Tumor Biotherapy Foundation | 2015-10-01 |
| Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN (NCT02570828) | Massachusetts General Hospital | 2015-10-01 |
| TNS for Treating Major Depressive Disorder in the Elderly (NCT02562677) | Santa Casa Medical School | 2015-10-01 |
| Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin (NCT02750709) | Cycle Pharmaceuticals Ltd. | 2015-10-01 |
| A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers (NCT02514603) | Eli Lilly and Company | 2015-10-01 |
| Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy (NCT02483871) | Duke University | 2015-10-01 |
| Fecal Transplant in Recurrent Hepatic Encephalopathy (NCT02636647) | Jasmohan Bajaj | 2015-10-01 |
| Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers (NCT02380976) | Daewon Pharmaceutical Co., Ltd. | 2015-10-01 |
| A Study of TAS-303 in Female Patients With Stress Urinary Incontinence (NCT02562807) | Taiho Pharmaceutical Co., Ltd. | 2015-10-01 |